Capital health expenditure in Argentina has shown significant fluctuation over the past decade, experiencing various declines and increments. The period from 2013 to 2023 saw a mixed bag of growth and contractions, with sharp decreases noted in 2017 and consistent declines observed from 2020 onwards. The year-on-year variations were particularly erratic, with a substantial 59.47% increase in 2013 and a pronounced -69.38% drop in 2017. The last two years saw persistent declines with -5.43% for 2023. As of 2023, the capital health expenditure stood at 0.012 units of GDP. The 5-year CAGR leading up to 2023 averaged -5.1% annually.
Looking ahead, the forecasted data indicates a continuation of the downward trend in capital health expenditure, dropping further at an average annual rate of -5.66% CAGR over the next five years, leading to a total decline of -25.29% by 2028.
Future Trends to Watch for:
- Potential impact of economic recovery plans on healthcare investment.
- Government policy changes aimed at boosting healthcare funding.
- Effect of international aid and investment in Argentina’s healthcare sector.
- Emerging healthcare technologies and their influence on capital allocation.
Latest reports
US Autoimmune Disease Market Report- Q1 2025
The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...
China Autoimmune Disease Market Report- Q1 2025
The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...
Japan Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...
Germany Autoimmune Disease Market Report- Q4 2024
The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...
UK Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...
South Korea Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...